{"count":10,"index":{"built_at":"2026-07-28T14:13:39.446483+00:00","public_records":55311,"revision":"9facbd91461475c2abc63910"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: TCF7L2 in the context of stress"},"results":[{"answer":"TCF7L2 is a transcription factor central to Wnt signaling and glucose homeostasis. GWAS studies have consistently identified variants in TCF7L2 (e.g., rs7903146) as the strongest genetic risk factors for type 2 diabetes. The link to 'stress' is less clear. 'Stress' could refer to metabolic stress (e.g., overnutrition, inflammation) or psychological stress (e.g., cortisol elevation). Some evidence suggests TCF7L2 variants may impair insulin secretion under stress conditions, but this is largely mechanistic or derived from GWAS, not from direct human stress provocation studies. Effect sizes are moderate, and lifestyle factors (diet, exercise) have a greater impact on stress response. A DNA test for TCF7L2 alone does not predict individual stress reactivity. Clinical relevance for stress management is currently low. Evidence: gwas/mechanistic.","area":"gesundheit","canonical_id":"gesundheit:canonical-9a74a4aaade32d5093970b7f","id":"public-5e383e146703437e5ec0dca2","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: TCF7L2 in the context of stress","score":18.50890541,"snippet":"TCF7L2 is a transcription factor central to Wnt signaling and glucose homeostasis. GWAS studies have consistently identified variants in TCF7L2 (e.g., rs7903146) as the strongest genetic risk factors for type 2 diabetes. The link to 'stress' is less clear. 'Stress' could refer to metabolic stress (e.g., overnutrition, inflammation) or psychological stress (e.g., cortisol elevation). Some evidence suggests TCF7L2 variants may impair insulin secretion under stress conditions, but this is largely mechanistic or derived from GWAS, not from direct human stress provocation studies. Effect sizes are moderate, and lifestyle factors (diet, exercise) have a greater impact on stress response. A DNA tes","sources":[],"title":"Evidence check: TCF7L2 in the context of stress","url":"https://tikki.wiki/wissen/gesundheit/frage/public-5e383e146703437e5ec0dca2/evidence-check-tcf7l2-in-the-context-of-stress/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"TCF7L2 is a transcription factor central to Wnt signaling. Multiple GWAS (e.g., PMID 17463246, 17463248) have firmly linked variants in this gene to increased risk of type 2 diabetes. Fatigue is not a direct outcome of TCF7L2 variation. However, undiagnosed or poorly managed diabetes can cause fatigue, creating an indirect but clinically relevant link. A consumer DNA test reporting TCF7L2 variants provides a risk indicator, not a diagnosis. Effect sizes are moderate, and lifestyle factors (diet, exercise, stress) play a larger role. Persistent fatigue warrants medical evaluation including blood glucose and HbA1c. The evidence for a direct TCF7L2–fatigue connection is weak; strong evidence exists only for diabetes. Interpretation should be cautious and contextual.","area":"gesundheit","canonical_id":"gesundheit:canonical-8a971fb8909165d6a63c5b63","id":"public-a1c78018ed1a551eeaf5eddb","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: TCF7L2 in the context of Müdigkeit","score":17.97422294,"snippet":"TCF7L2 is a transcription factor central to Wnt signaling. Multiple GWAS (e.g., PMID 17463246, 17463248) have firmly linked variants in this gene to increased risk of type 2 diabetes. Fatigue is not a direct outcome of TCF7L2 variation. However, undiagnosed or poorly managed diabetes can cause fatigue, creating an indirect but clinically relevant link. A consumer DNA test reporting TCF7L2 variants provides a risk indicator, not a diagnosis. Effect sizes are moderate, and lifestyle factors (diet, exercise, stress) play a larger role. Persistent fatigue warrants medical evaluation including blood glucose and HbA1c. The evidence for a direct TCF7L2–fatigue connection is weak; strong evidence ex","sources":[],"title":"Evidence check: TCF7L2 in the context of Müdigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a1c78018ed1a551eeaf5eddb/evidence-check-tcf7l2-in-the-context-of-muedigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"TCF7L2 is a transcription factor best known for its strong association with type 2 diabetes risk. In the context of skin aging, no robust human studies have established a direct, clinically meaningful link. Mechanistic evidence suggests involvement in Wnt signaling, which may influence cell proliferation and collagen synthesis, but this remains speculative. Direct-to-consumer DNA tests that claim to predict skin aging from TCF7L2 variants typically rely on insufficient or purely preclinical data. The evidence level is therefore 'mechanistic' or 'unclear'. Even where diabetes associations are well-replicated, extrapolation to skin aging processes is not justified. For assessing skin aging factors such as collagen degradation or oxidative stress, validated biomarkers (e.g., skin measurements, lifestyle factors) are more appropriate than single SNPs. Medical consultation is recommended before interpreting such genetic tests.","area":"gesundheit","canonical_id":"gesundheit:canonical-c5906b5ef8f3fab21f8892c8","id":"public-2ceec19115ef237fcc862e37","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: TCF7L2 in the context of skin aging","score":17.69724314,"snippet":"TCF7L2 is a transcription factor best known for its strong association with type 2 diabetes risk. In the context of skin aging, no robust human studies have established a direct, clinically meaningful link. Mechanistic evidence suggests involvement in Wnt signaling, which may influence cell proliferation and collagen synthesis, but this remains speculative. Direct-to-consumer DNA tests that claim to predict skin aging from TCF7L2 variants typically rely on insufficient or purely preclinical data. The evidence level is therefore 'mechanistic' or 'unclear'. Even where diabetes associations are well-replicated, extrapolation to skin aging processes is not justified. For assessing skin aging fac","sources":[],"title":"Evidence check: TCF7L2 in the context of skin aging","url":"https://tikki.wiki/wissen/gesundheit/frage/public-2ceec19115ef237fcc862e37/evidence-check-tcf7l2-in-the-context-of-skin-aging/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The 'Cardio Risk Check' or 'Herz-Kreislauf Risiko-Test' you mention is not directly addressed in the provided context. The available information covers individual genetic variants such as TCF7L2 (rs7903146) and FTO (rs9939609), which are associated with metabolic traits but not specifically with cardiovascular events or fatigue. Evidence for such polygenic risk scores is mostly population-based (GWAS) with small effect sizes (e.g., OR ~1.4 for TCF7L2). A direct link between this test and the symptom 'fatigue' is scientifically unsupported. Fatigue has numerous causes (sleep deprivation, stress, iron deficiency, thyroid dysfunction, psychological factors) that a DNA test cannot capture. The clinical utility of such tests for individual risk stratification or symptom explanation is questionable. Without specific studies linking the test to fatigue, the evidence must be rated as 'marketing' or 'unclear'. A proper fatigue workup should rely on established clinical parameters (blood count, inflammatory markers, sleep diary), not a genetic test.","area":"gesundheit","canonical_id":"gesundheit:canonical-bd08c3618b457cfc8b79edf2","id":"public-539382669f8e0d502963ec85","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of fatigue","score":17.076508,"snippet":"The 'Cardio Risk Check' or 'Herz-Kreislauf Risiko-Test' you mention is not directly addressed in the provided context. The available information covers individual genetic variants such as TCF7L2 (rs7903146) and FTO (rs9939609), which are associated with metabolic traits but not specifically with cardiovascular events or fatigue. Evidence for such polygenic risk scores is mostly population-based (GWAS) with small effect sizes (e.g., OR ~1.4 for TCF7L2). A direct link between this test and the symptom 'fatigue' is scientifically unsupported. Fatigue has numerous causes (sleep deprivation, stress, iron deficiency, thyroid dysfunction, psychological factors) that a DNA test cannot capture. The c","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of fatigue","url":"https://tikki.wiki/wissen/gesundheit/frage/public-539382669f8e0d502963ec85/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-fatigue/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The MyBody-X DNA Nutrition Test analyzes genetic variants linked to carbohydrate metabolism (e.g., TCF7L2, GCKR) and glycemic response. The underlying evidence comes from GWAS and observational studies showing small effect sizes – for instance, carriers of the TCF7L2 rs7903146 T-allele may respond better to a low-fat, high-carb diet. However, results are conflicting (e.g., the DIETFITS trial found no genotype-diet interaction). The test is designed for lifestyle inspiration, not medical diagnosis. For weight loss, calorie balance, exercise, sleep, and stress play far larger roles than individual gene variants. Effect sizes are small, and data are often limited to European populations. There is no clinical validation for weight reduction. Therefore, the test is insufficient for anyone seeking concrete medical or nutritional decisions. It may serve as an extra nudge toward a healthier lifestyle but does not replace professional medical or dietary advice. Caution: Do not use for disease screening or treatment planning.","area":"gesundheit","canonical_id":"gesundheit:canonical-8be28cc0440a4ac1047d3377","id":"public-9769fb0ee80650e44c20a4e4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Fitness | LifestyleCheck in the context of Blutzucker","score":16.92824867,"snippet":"The MyBody-X DNA Nutrition Test analyzes genetic variants linked to carbohydrate metabolism (e.g., TCF7L2, GCKR) and glycemic response. The underlying evidence comes from GWAS and observational studies showing small effect sizes – for instance, carriers of the TCF7L2 rs7903146 T-allele may respond better to a low-fat, high-carb diet. However, results are conflicting (e.g., the DIETFITS trial found no genotype-diet interaction). The test is designed for lifestyle inspiration, not medical diagnosis. For weight loss, calorie balance, exercise, sleep, and stress play far larger roles than individual gene variants. Effect sizes are small, and data are often limited to European populations. There ","sources":[],"title":"Evidence check: Fitness | LifestyleCheck in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-9769fb0ee80650e44c20a4e4/evidence-check-fitness-lifestylecheck-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided context does not directly address insulin in the context of stress. However, established human physiology shows that stress hormones (cortisol, adrenaline) raise blood glucose, and chronic stress can promote insulin resistance via increased cortisol and inflammation. Human studies (e.g., on shift workers or chronic stress) demonstrate moderate associations between stress markers and elevated fasting insulin or HOMA-IR. The evidence level is human-moderate, but no specific sources from the given context support this. Consumer tests (DNA, blood) from MyBody-X may include markers like fasting insulin or SNPs related to insulin sensitivity (e.g., TCF7L2), but effect sizes are small and results are not diagnostic. For clinical assessment, a doctor should evaluate stress-related metabolic changes using validated tests (e.g., OGTT, cortisol rhythm). The evidence rating reflects general medical knowledge, not the provided context. Caution: Do not self-adjust medications or supplements based on home test results.","area":"gesundheit","canonical_id":"gesundheit:canonical-cf490457e1818bf9d5ffc8c6","id":"public-7942194acec6861714147d88","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Insulin in the context of stress","score":16.83830765,"snippet":"The provided context does not directly address insulin in the context of stress. However, established human physiology shows that stress hormones (cortisol, adrenaline) raise blood glucose, and chronic stress can promote insulin resistance via increased cortisol and inflammation. Human studies (e.g., on shift workers or chronic stress) demonstrate moderate associations between stress markers and elevated fasting insulin or HOMA-IR. The evidence level is human-moderate, but no specific sources from the given context support this. Consumer tests (DNA, blood) from MyBody-X may include markers like fasting insulin or SNPs related to insulin sensitivity (e.g., TCF7L2), but effect sizes are small ","sources":[],"title":"Evidence check: Insulin in the context of stress","url":"https://tikki.wiki/wissen/gesundheit/frage/public-7942194acec6861714147d88/evidence-check-insulin-in-the-context-of-stress/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"A DNA metabolism test for blood sugar typically examines variants in genes like TCF7L2, MTNR1B, or ARNTL. The evidence is mostly human-moderate to GWAS-based. For example, the TCF7L2 risk variant (T-allele) increases diabetes risk, but trials like DPP, POUNDS LOST, and DIETFITS show no consistent gene-diet interaction – low-carb is not universally better. The MTNR1B variant affects melatonin signaling and may impair blood sugar regulation with late meals, but effect sizes are small. The ARNTL SNP (rs3789327) is linked to chronotype, but a single SNP has minimal predictive value. In summary, these tests offer clues but not actionable clinical guidance. Blood sugar is far more influenced by diet, exercise, sleep, and stress than by single genes. Beware of exaggerated marketing claims. A DNA test does not replace medical blood sugar monitoring or lifestyle counseling.","area":"gesundheit","canonical_id":"gesundheit:canonical-1df7fecbbc498ef2a2cd591b","id":"public-b8c38a0a763c615d17d6e794","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: DNA Stoffwechseltest in the context of blood sugar","score":16.82254262,"snippet":"A DNA metabolism test for blood sugar typically examines variants in genes like TCF7L2, MTNR1B, or ARNTL. The evidence is mostly human-moderate to GWAS-based. For example, the TCF7L2 risk variant (T-allele) increases diabetes risk, but trials like DPP, POUNDS LOST, and DIETFITS show no consistent gene-diet interaction – low-carb is not universally better. The MTNR1B variant affects melatonin signaling and may impair blood sugar regulation with late meals, but effect sizes are small. The ARNTL SNP (rs3789327) is linked to chronotype, but a single SNP has minimal predictive value. In summary, these tests offer clues but not actionable clinical guidance. Blood sugar is far more influenced by di","sources":[],"title":"Evidence check: DNA Stoffwechseltest in the context of blood sugar","url":"https://tikki.wiki/wissen/gesundheit/frage/public-b8c38a0a763c615d17d6e794/evidence-check-dna-stoffwechseltest-in-the-context-of-blood-sugar/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The NutriCare INFINITY DNA Test marketed for blood sugar (Blutzucker) claims to provide personalized dietary advice based on genetic variants. However, the scientific evidence is limited. While GWAS have identified variants in genes like TCF7L2 and GCKR associated with fasting glucose and type 2 diabetes risk, their effect sizes are small and not clinically actionable for most individuals. Blood sugar regulation is predominantly influenced by lifestyle factors (diet, exercise, weight, stress). The test lacks clinical validation for diagnosis or personalized nutrition guidance. It should not replace standard medical tests (e.g., HbA1c, OGTT). Evidence level: GWAS associations with weak predictive value, often overhyped in marketing. Caution: Do not adjust medications based solely on such consumer genetic results without professional oversight.","area":"gesundheit","canonical_id":"gesundheit:canonical-c0ae49b99e82b3672007ca96","id":"public-e5c6ee67aeb4f8ff02a6c417","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: NutriCare | INFINITY DNA-Test in the context of Blutzucker","score":16.35219792,"snippet":"The NutriCare INFINITY DNA Test marketed for blood sugar (Blutzucker) claims to provide personalized dietary advice based on genetic variants. However, the scientific evidence is limited. While GWAS have identified variants in genes like TCF7L2 and GCKR associated with fasting glucose and type 2 diabetes risk, their effect sizes are small and not clinically actionable for most individuals. Blood sugar regulation is predominantly influenced by lifestyle factors (diet, exercise, weight, stress). The test lacks clinical validation for diagnosis or personalized nutrition guidance. It should not replace standard medical tests (e.g., HbA1c, OGTT). Evidence level: GWAS associations with weak predic","sources":[],"title":"Evidence check: NutriCare | INFINITY DNA-Test in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e5c6ee67aeb4f8ff02a6c417/evidence-check-nutricare-infinity-dna-test-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided knowledge context does not contain specific information about a 'Menopause Check' in relation to blood sugar. The documents cover a gut self-test, an APOA5 SNP (rs662799) linked to triglycerides, and general DNA tests for stress and insulin resistance (TCF7L2). None of these directly address menopause or its impact on glucose metabolism. It is well established that menopause involves hormonal shifts (declining estrogen) that can reduce insulin sensitivity and increase blood sugar variability, but this is not discussed in the given texts. A 'Menopause Check' as a product category (e.g., hormone or DNA test) would need separate evaluation. Evidence for such checks is often weak because blood sugar regulation is multifactorial, and single biomarkers or genes have small effects. Without specific studies or clinical guidelines in the context, the evidence remains unclear. Consumers should not rely on isolated test results but seek medical advice, especially for menopausal symptoms and metabolic health.","area":"gesundheit","canonical_id":"gesundheit:canonical-532ab799a5b9663a2b201f9d","id":"public-b742129bb8f845c67fd42537","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Menopause Check in the context of blood sugar","score":16.25855954,"snippet":"The provided knowledge context does not contain specific information about a 'Menopause Check' in relation to blood sugar. The documents cover a gut self-test, an APOA5 SNP (rs662799) linked to triglycerides, and general DNA tests for stress and insulin resistance (TCF7L2). None of these directly address menopause or its impact on glucose metabolism. It is well established that menopause involves hormonal shifts (declining estrogen) that can reduce insulin sensitivity and increase blood sugar variability, but this is not discussed in the given texts. A 'Menopause Check' as a product category (e.g., hormone or DNA test) would need separate evaluation. Evidence for such checks is often weak be","sources":[],"title":"Evidence check: Menopause Check in the context of blood sugar","url":"https://tikki.wiki/wissen/gesundheit/frage/public-b742129bb8f845c67fd42537/evidence-check-menopause-check-in-the-context-of-blood-sugar/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The 'WeightLoss Slim DNA' test in the context of blood sugar claims to analyze genetic variants affecting metabolism and insulin sensitivity. However, the scientific evidence for such direct links is weak. While GWAS studies have identified genes (e.g., TCF7L2, PPARG) associated with blood sugar regulation, effect sizes are small and predictive power for individual weight loss or glucose trajectories is low. Blood sugar is heavily influenced by diet, exercise, sleep, and stress – factors a DNA test cannot capture. Most commercial tests rely on mechanistic or population-based data that are not clinically validated for individual use. Relying solely on DNA analysis for blood sugar management is not recommended. Established methods like fasting glucose, HbA1c, or continuous glucose monitoring combined with dietary counseling are more evidence-based. The test may serve as supplementary insight but should not guide medical decisions. Evidence: mixed/unclear.","area":"gesundheit","canonical_id":"gesundheit:canonical-4a746a54069ade97ef446782","id":"public-3e4316cc3f2c07893199e2e0","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: WeightLoss Slim DNA in the context of Blutzucker","score":16.18865929,"snippet":"The 'WeightLoss Slim DNA' test in the context of blood sugar claims to analyze genetic variants affecting metabolism and insulin sensitivity. However, the scientific evidence for such direct links is weak. While GWAS studies have identified genes (e.g., TCF7L2, PPARG) associated with blood sugar regulation, effect sizes are small and predictive power for individual weight loss or glucose trajectories is low. Blood sugar is heavily influenced by diet, exercise, sleep, and stress – factors a DNA test cannot capture. Most commercial tests rely on mechanistic or population-based data that are not clinically validated for individual use. Relying solely on DNA analysis for blood sugar management i","sources":[],"title":"Evidence check: WeightLoss Slim DNA in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3e4316cc3f2c07893199e2e0/evidence-check-weightloss-slim-dna-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}